Adynerin is a monoglycosidic cardenolide cardiac glycoside primarily derived from Nerium oleander, recognized for its role as an inhibitor of the Na+/K+-ATPase pump to help regulate ion homeostasis. Due… Read more
Adynerin is a monoglycosidic cardenolide cardiac glycoside primarily derived from Nerium oleander, recognized for its role as an inhibitor of the Na+/K+-ATPase pump to help regulate ion homeostasis. Due to its significant effects on heart muscle contraction, this compound and its related structures are subjects of intense study in cardiovascular physiology and pharmacology. Laboratories require high-quality reference standards for these cardenolides to facilitate rigorous impurity profiling, structural characterization, and method validation. The inclusion of stable isotope labelled compounds and specific metabolites in this category supports precise analytical testing and quantitation in complex matrices. Researchers utilize these reference materials for quality control and the development of assays to monitor the presence and stability of related cardiac glycosides, ensuring accuracy in pharmacological investigations and the advancement of research into cardiac drug mechanisms.